Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €88.40 EUR
Change Today -0.68 / -0.76%
Volume 1.1M
As of 9:12 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David-Alexandre Gros

Former Chief Strategy Officer and Executive Vice President, Sanofi
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

43--

Background*

Dr. David-Alexandre Gros has been Senior Vice President and Chief Business Officer of Alnylam Pharmaceuticals, Inc. since June 8, 2015 and serves as its Member of Management Board. Dr. Gros served as the Chief Strategy Officer and Executive Vice President at Sanofi since September 1, 2011. Dr. Gros covers all Group business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management. ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: 33 1 53 77 42 96

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA 2002
Harvard Business School
BA 1995
Dartmouth College
MD 1999
Johns Hopkins School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €88.40 EUR -0.68

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
$1.5M
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
70.0K GBP
Edward M. Kaye M.D., Ph.D.Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President
Sarepta Therapeutics, Inc.
$399.0K
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
$580.0K
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.